COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 2032: Articles 20311-20320  | Next

Clinical Characteristics and Risk Factors for Myocardial Injury and Arrhythmia in COVID-19 patients
Ren, H. G., Guo, X., Tu, L., Hu, Q., Blighe, K., Safdar, L. B., Stebbing, J., Weiner, S. D., Willis, M. S., Rosendaal, F. R., Xu, G., Cao, F., Wang, D. W.
10.1101/2020.11.30.20190926 — Posted: 2020-12-03 Discussion: Offsite
Application of respiratory metagenomics for COVID-19 patients on the intensive care unit to inform appropriate initial antimicrobial treatment and rapid detection of nosocomial transmission
Charalampous, T., Alcolea-Medina, A., Snell, L. B., Williams, T. G. S., Batra, R., Camporota, L., Meadows, C. I. S., Wyncoll, D., Barrett, N. A., Hemsley, C. J., Bryan, L., Newsholme, W., Boyd, S. E., Green, A., Mahadeva, U., Patel, A., Cliff, P., Page, A. J., O'Grady, J., Edgeworth, J. D.
10.1101/2020.11.26.20229989 — Posted: 2020-12-03
Is Point-of-Care testing feasible and safe in care homes in England? An exploratory usability and accuracy evaluation of Point-of-Care Polymerase Chain Reaction test for SARS-COV-2
Micocci, M., Gordon, A., Seo, M. K., Allen, J. A., Davies, K., Lasserson, D., Thompson, C., Spilsbury, K., Akrill, C., Heath, R., Astle, A., Sharpe, C., Perrera, R., Buckle, P.
10.1101/2020.11.30.20240010 — Posted: 2020-12-03
MTX-COVAB, a human-derived antibody with potent neutralizing activity against SARS-CoV-2 infection in vitro and in a hamster model of COVID-19
Esslinger, C., Schmitt, S., Weber, M., Hillenbrand, M., Seidenberg, J., Zingg, A., Townsend, C., Eicher, B., Rutkauskaite, J., Riese, P., Guzman, C. A., Fischer, K.
10.1101/2020.12.01.406934 — Posted: 2020-12-02
COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types.
Schmiedel, B. J., Chandra, V., Rocha, J., Gonzalez-Colin, C., Bhattacharyya, S., Madrigal, A., Ottensmeier, C. H., Ay, F., Vijayanand, P.
10.1101/2020.12.01.407429 — Posted: 2020-12-02
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
Puhl, A. C., Fritch, E. J., Lane, T. R., Tse, L. V., Yount, B., Sacramento, C. Q., Tavella, T. A., Costa, F. T. M., Weston, S., Logue, J., Frieman, M., Premkumar, L., Pearce, K. H., Hurst, B. L., Andrade, C. H., Levi, J. A., Johnson, N. J., Kisthardt, S. C., Scholle, F., Souza, T. M., Moorman, N. J., Baric, R. S., Madrid, P., Ekins, S.
10.1101/2020.12.01.407361 — Posted: 2020-12-02 Discussion: Onsite
Effective in-vitro inactivation of SARS-CoV-2 by commercially available mouthwashes
Davies, K., Buczkowski, H., Welch, S. R., Green, N., Mawer, D., Woodford, N., Roberts, A. D. G., Nixon, P., Seymour, D., Killip, M. J.
10.1101/2020.12.02.408047 — Posted: 2020-12-02
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 in Vitro
Gammeltoft, K. A., Zhou, Y., Galli, A., Offersgaard, A., Pham, L. V., Fahnoe, U., Feng, S., Ramirez, S., Bukh, J., Gottwein, J. M.
10.1101/2020.12.02.408112 — Posted: 2020-12-02
Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues
Yang, F., Nielsen, S. A., Hoh, R. A., Lee, J.-Y., Pham, T. D., Jackson, K. J. L., Roskin, K. M., Liu, Y., Ohgami, R. S., Osborne, E. M., Niemann, C. U., Parsonnet, J., Boyd, S. D.
10.1101/2020.12.01.407015 — Posted: 2020-12-02
LL-37 fights SARS-CoV-2: The Vitamin D-Inducible Peptide LL-37 Inhibits Binding of SARS-CoV-2 Spike Protein to its Cellular Receptor Angiotensin Converting Enzyme 2 In Vitro
Roth, A., Luetke, S., Meinberger, D., Hermes, G., Sengle, G., Koch, M., Streichert, T., Klatt, A. R.
10.1101/2020.12.02.408153 — Posted: 2020-12-02 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).